Jon Faiz Kayyem, SVP, Research & Development at GenMark Diagnostics, Inc. (GNMK), sold 1,277 shares at $9.45 ($12K) on 2017-08-21, disclosed to the SEC on 2017-08-23.
Open-market sale of $12k GNMK by SVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| INBX | BUY | 2026-09-08 | $568K | — | Filing → |
| INBX | BUY | 2024-11-22 | $1.5M | — | Filing → |
| INBX | BUY | 2024-06-07 | $2.0M | — | Filing → |